December 2020 Edition
Anna Francis, Pediatric Nephrologist and Kidney International Fellowship Intern, interviews Kidney International Associate Editors on the challenges of dialysis and transplantation during the COVID-19 pandemic:
- Jai Radhakrishan, Professor of Medicine, Colombia University Medical Center, USA, discusses what is known on AKA and glomerulopathy related to COVID-19.
- Talat Alp Ikizler, Professor of Medicine, Vanderbilt University Medical Center, USA, reports on issues relating to COVID-19 and dialysis.
- Toby Coates, Professor of Medicine Renal Transplantation, University of Adelaide, Australia, outlines what registry data on treating transplant patients during the COVID era indicates.
The editors intend for nephrologists to draw on these global experiences to help their daily care of patients
IMPact of the COVID-19 epidemic on the moRTAlity of renal transplant recipients and candidates…
– Visual abstract by Edgar Lerma @edgarvlermamd
Outcomes of Patients with End-stage Kidney Disease Hospitalized with COVID-19
– Visual abstract by Aakash Shingada @aakashshingada
COVID-19 and Dialysis: How to Prevent and Manage?
By Talat Alp Ikizler – Director of Division of Nephrology and Hypertension, Professor of Medicine and Catherine McLaughlin Hakim – Chair in Vascular Biology, Vanderbilt University School of Medicine, USA.
Associate Editor, Kidney International.
 |
KIDNEY INTERNATIONAL ARTICLES |
Ethics of Kidney Care in the Era of COVID-19
The pandemic has stretched all health care systems to critical levels. Nephrologists have been placed under considerable pressure during the crisis and have been charged with allocation of resources that have raised ethical concerns. This article describes such concerns and provides practical advice on how to approach these.
COVID-19 Infection in Kidney Transplant Recipients at the Epicenter of Pandemics
The pandemic has made kidney transplantation and the need for chronic immunosuppression a priority issue among nephrologists. This paper, reports the transplant experience from Bronx, New York, one of the hardest hit areas in the United States.
Results from the ERA-EDTA Registry Indicate a High Mortality Due to COVID-19 in Dialysis Patients and Kidney Transplant Recipients Across Europe
Results from the ERA-EDTA Registry published in Kidney International show that the pandemic has had a substantial effect on mortality in patients receiving kidney replacement therapy, a highly vulnerable population due to underlying chronic kidney disease and a high prevalence of associated morbidities.
 |
KIDNEY INTERNATIONAL REPORTS ARTICLES |
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy
In one of the most highly cited articles to be published in KI Reports, nephrologists in Brescia, Italy, on the front lines of the COVID-19 pandemic, discuss the challenges and successes of treating patients on dialysis who’ve received kidney transplants.
Collapsing Glomerulopathy in a Patient With COVID-19
Another very well-read COVID article is a case report by doctors at the Arkana Labs, Little Rock, AK, and Tulane University, New Orleans, LA, who discuss the presentation, etiology, disease course and treatment of an African-American patient with COVID-19 and collapsing glomerulopathy.